Sucampo Reports Strong Results for First Quarter of 2016
May 04, 2016 06:30 ET
|
Sucampo Pharmaceuticals Inc
Results Driven by 60% Growth in Revenue Company Reiterates 2016 Guidance Company to Host Conference Call Today at 8:30 a.m. EDT ROCKVILLE, Md., May 04, 2016 (GLOBE NEWSWIRE) -- Sucampo...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Bank of America Merrill Lynch 2016 Healthcare Conference
May 03, 2016 06:45 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., May 03, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Announces First Quarter 2016 Earnings Call
April 20, 2016 06:45 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., April 20, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its first quarter...
Sucampo Reports Top-Line Data from Phase 2a Study of Cobiprostone in Patients with PPI-Refractory Non-Erosive Reflux Disease (NERD) and Symptomatic Gastroesophageal Reflux Disease (sGERD)
April 19, 2016 07:00 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., April 19, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced top-line data from a Phase 2a study of...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 28th Annual ROTH Conference
March 09, 2016 06:45 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., March 09, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Reports Continued Strong Performance for Fourth Quarter and Full Year 2015
March 08, 2016 06:30 ET
|
Sucampo Pharmaceuticals Inc
Results Driven by Continued AMITIZA Growth and R-TECH UENO Acquisition Company Reiterates 2016 Guidance Company to Host Conference Call Today at 8:30 a.m. EST ROCKVILLE, Md., March 08, 2016 ...
Sucampo Announces Fourth Quarter and Full Year 2015 Earnings Call
February 23, 2016 06:45 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its fourth quarter...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2016 Leerink Global Healthcare Conference
February 04, 2016 06:30 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
Sucampo Enters Into Exclusive Option and Collaboration Agreement With Cancer Prevention Pharmaceuticals for Development of Late-Stage CPP-1X/Sulindac Combination for Familial Adenomatous Polyposis
January 11, 2016 06:45 ET
|
Sucampo Pharmaceuticals Inc
Addresses Significant Patient Need Aligned With GI Expertise, Strategic Focus Phase 3 Study Expected to be Complete in 2018 ROCKVILLE, Md., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Sucampo...
Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno Acquisition
January 07, 2016 07:00 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today provided additional detail regarding its...